TIOSPIR®: Large scale trial of tiotropium Respimat® vs HandiHaler® (HH) in patients (pts) with COPD
R. Wise, A. Anzueto, P. Calverley, R. Dahl, D. Dusser, G. Pledger, M. Koenen-Bergmann, E. Joseph, D. Cotton, B. Disse (Baltimore, San Antonio, Hamilton, Ridgefield, United States Of America; Liverpool, United Kingdom; Aarhus, Denmark; Paris, France; Ingelheim, Germany)
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Wise, A. Anzueto, P. Calverley, R. Dahl, D. Dusser, G. Pledger, M. Koenen-Bergmann, E. Joseph, D. Cotton, B. Disse (Baltimore, San Antonio, Hamilton, Ridgefield, United States Of America; Liverpool, United Kingdom; Aarhus, Denmark; Paris, France; Ingelheim, Germany). TIOSPIR®: Large scale trial of tiotropium Respimat® vs HandiHaler® (HH) in patients (pts) with COPD. Eur Respir J 2013; 42: Suppl. 57, 752
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: